The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
Open accessAbstract
Recurrent skin infections in extrinsic atopic dermatitis (EAD) may be because of the suppression of anti-microbial peptide (AMP) expression by interleukin (IL)-4 and IL-13. Twenty to thirty percent of AD, however, are classified as intrinsic atopic dermatitis (IAD). They exhibit normal serum IgE levels, no allergen-specific sensitization, and lower levels of IL-4 and IL-13 than EAD. Both forms of AD have increased propensity to skin infection, suggesting a novel mechanism for infection in IAD. In this study, we observed significantly decreased human beta-defensin (HBD)-2 gene expression in the skin of both IAD (p = 0.010) and EAD (p = 0.004), as compared with psoriasis patients. Conversely, IAD (p = 0.019) and EAD (p = 0.002) skin lesions exhibited elevated IL-10 gene expression when compared with psoriasis. Using primary keratinocytes, we found that the deficiency in AMP expression is an acquired rather than a constitutive defect. Interestingly, neutralizing antibodies to IL-10 augmented the production of tumor necrosis factor-alpha and interferon-gamma by peripheral blood mononuclear cell from AD patients. Additionally, treatment of AD skin explants with anti-IL-10 augmented the expression of both HBD-2 and LL-37. Thus, increased levels of IL-10 may contribute to the AMP deficiency in both IAD and EAD by reducing cytokines that induce AMP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AMP expression is highly dependent on the cytokine milieu present in the skin and proinflammatory cytokines, such as IL-1, IL-6, IL-8, and tumor necrosis factor α (TNFα), are typically strong inducers of AMPs, whereas IL-4, IL-13, and IL-10 have been shown to dampen AMP responses.33–35”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [35]
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,597
Self-citationde Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.591 · Cited by 2,391
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Self-citationNew insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Self-citationD’Andrea, A., Aste-Amézaga, M., Valiante, N. M., Ma, X., Kubin, M. Z., & Trinchieri, G. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,367
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J. ‐. (1997) · Nature · doi:10.1038/43088 · Cited by 1,365
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Self-citation
Cited by
Sorted by citations
Items 101–193 of 193
Expression and distribution of antimicrobial peptides in the skin of healthy beagles
Santoro, D., Bunick, D., Graves, T. K., & CAMPBELL, K. L. (2010) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2010.00911.x · Cited by 25
Park, A. J., Okhovat, J., & Kim, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_6 · Cited by 27
Santoro, D., Ahrens, K. P., Marsella, R., & Segre, M. (2015) · Experimental Dermatology · doi:10.1111/exd.12660 · Cited by 24
IL-10 inhibits while calcitriol reestablishes placental antimicrobial peptides gene expression
Olmos‐Ortiz, A., Noyola-Martínez, N., Barrera, D., Zaga‐Clavellina, V., Avila, E., Halhali, A., Biruete, B., Larrea, F., & Dı́az, L. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.012 · Cited by 23
Inaba, Y., Ashida, T., Ito, T., Ishikawa, C., Tanabe, H., Maemoto, A., Watari, J., Ayabe, T., Mizukami, Y., Fujiya, M., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21253 · Cited by 23
Ostorházi, E., Hoffmann, R., Herth, N., Wade, J. D., Kraus, C. N., & Otvos, L. J. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00359 · Cited by 23
Goo, J., Ji, J. H., Jeon, H., Kim, M. J., Jeon, S.-Y., Cho, M.-Y., Lee, S. H., & Choi, E. H. (2010) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2010.01122.x · Cited by 23
Zhang, C., Zhao, L., Ma, L., Lv, C., Ding, Y., Xia, T., Wang, J., & Dou, X. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1824-6 · Cited by 22
Darling, A., Freyschmidt, E., Burton, O. T., Koleoglou, K. J., Oyoshi, M. K., & Oettgen, H. C. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.11.010 · Cited by 22
Al‐Janabi, A., Martin, P., Khan, A. R., Foulkes, A., Smith, C. H., Griffiths, C. E. M., Morris, A. P., Eyre, S., Warren, R. B., Ahmed, S., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.011 · Cited by 21
Wang, J., Liu, X., Wang, H., Li, Y., Lan, N., Yuan, X., Wu, M., Liu, Z., & Li, G. (2017) · Oncotarget · doi:10.18632/oncotarget.19826 · Cited by 20
Fagundes, B. O., de Sousa, T. R., & Victor, J. R. (2022) · International Journal of Dermatology · doi:10.1111/ijd.16364 · Cited by 21
Makowska, J., Wyrzykowski, D., Kamysz, E., Tesmar, A., Kamysz, W., & Chmurzyński, L. (2019) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-019-08310-9 · Cited by 19
Clinical correlations of recent developments in the pathogenesis of atopic dermatitis
Sehra, S., Barbé‐Tuana, F. M., Holbreich, M., Mousdicas, N., Kaplan, M. H., & Travers, J. B. (2008) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962008000100009 · Cited by 19
Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
Szabó, L., Kapitány, A., Somogyi, O., Alhafez, I., Gáspár, K., Palatka, R., Soltész, L., Törőcsik, D., Hendrik, Z., Dajnoki, Z., et al. (2023) · Acta Dermato Venereologica · doi:10.2340/actadv.v103.9413 · Cited by 17
Atopic dermatitis: molecular, cellular, and clinical aspects
Salimian, J., Salehi, Z., Ahmadi, A., Emamvirdizadeh, A., Davoudi, S. M., Karimi, M., Korani, M., & Jamalkandi, S. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07081-7 · Cited by 16
Lacy, K. E., Archer, C., Wood, N., & Bidwell, J. L. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00857.x · Cited by 16
Sigmundsdóttir, H. (2011) · Dermato-Endocrinology · doi:10.4161/derm.15115 · Cited by 18
Kawai, M., Yamazaki, M., Tsuboi, R., Miyajima, H., Ogawa, H., & Tsuboi, R. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.03111.x · Cited by 17
Red face revisited: Endogenous dermatitis in the form of atopic dermatitis and seborrheic dermatitis
Ramos-e-Silva, M., Sampaio, A. L., & Carneiro, S. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.05.032 · Cited by 16
Lernia, V. G. D. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.965682 · Cited by 15
Li, Q., Zhou, Y., Dong, K., & Guo, X. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2313-0 · Cited by 14
Break on Through: The Role of Innate Immunity and Barrier Defence in Atopic Dermatitis and Psoriasis
Hawerkamp, H. C., Fahy, C. M. R., Fallon, P. G., & Schwartz, C. (2022) · Skin Health and Disease · doi:10.1002/ski2.99 · Cited by 15
Lancto, C. A., Torres, S. M. F., Hendrickson, J. A., Martins, K. V., & Rutherford, M. S. (2013) · Veterinary Dermatology · doi:10.1111/vde.12034 · Cited by 14
Microbiosis in pathogenesis and intervention of atopic dermatitis
Dou, J., Zeng, J., Wu, K., Tan, W., Gao, L., & Lu, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.030 · Cited by 17
Human Polymorphisms as Clinical Predictors in Leprosy
de, E. P. M. (2011) · Journal of Tropical Medicine · doi:10.1155/2011/923943 · Cited by 13
Čelakovská, J., Čermáková, E., Boudková, P., & Krejsek, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604883 · Cited by 16
A nonsteroidal alternative to impetiginized eczema in the emergency room
Stoff, B. K., MacKelfresh, J. B., Fried, L. E., Cohen, C., & Arbiser, J. L. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.027 · Cited by 12
Role of Staphylococcus aureus in Atopic Dermatitis
Ong, P. Y. (2009) · CRC Press eBooks · doi:10.3109/9781420077995-16 · Cited by 11
From the bench to the clinic: New aspects on immunoregulation by vitamin D analogs.
Sigmundsdóttir, H. (2011) · Europe PMC (PubMed Central) · doi:10.4161/derm.3.3.15115 · Cited by 10
Antimicrobial Peptides in Cutaneous Wound Healing
Sørensen, O. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-24199-9_1 · Cited by 11
Etanercept decreases the innate immune wounding response in psoriasis
Hata, T. R., Afshar, M., Miller, J., Two, A. M., Kotol, P. F., Jackson, M., Alexandrescu, D. T., Kabigting, F. D., Gerber, M., Lai, Y., et al. (2013) · Experimental Dermatology · doi:10.1111/exd.12167 · Cited by 9
Self-citationThe role of cytokines in atopic dermatitis: a breakthrough in immunopathogenesis and treatment
Alsabbagh, M. M., & Ismaeel, A. (2022) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2022.3 · Cited by 10
Yoshida, S., Lee, J. O., Nakamura, K., Suzuki, S., Hendon, D. N., Kobayashi, M., & Suzuki, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082926 · Cited by 9
Topical calcineurin inhibitors
Luger, T. A., Steinhoff, M. S., Remitz, A., & Reitamo, S. (2008) · Series in dermatological treatment · doi:10.3109/9780203091449.019 · Cited by 9
Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment
Hassan, S., Hamideh, N., Poulos, C., Cheema, S., Rangwani, S. M., & Lio, P. (2021) · Dermatitis · doi:10.1097/der.0000000000000711 · Cited by 8
Gambichler, T., Reuther, J., Richards, C., & Doerler, M. (2020) · International Journal of Dermatology · doi:10.1111/ijd.15003 · Cited by 8
WEBSTER, G. F. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.1.105 · Cited by 8
Behniafard, N., Amirzargar, A., Gharagozlou, M., Delavari, F., Hosseinverdi, S., Sotoudeh, S., Farhadi, E., Mahmoudi, M., Khaledi, M., Moghaddam, Z. G., et al. (2018) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2017.05.007 · Cited by 7
Firouzabadi, A. M., Rezvani, M. E., Zare, F., Azizian, H., & Fesahat, F. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100887 · Cited by 7
Antimicrobial polypeptides and lipids as a part of innate defense mechanism of fish and human fetus
Bergsson, G. (2005) · Figshare · Cited by 7
Inflammation in Wound Repair: Role and Function of Inflammation in Wound Repair
MacLeod, A. S., & Kwock, J. T. (2017) · Wiley eBooks · doi:10.1002/9781119282518.ch14 · Cited by 7
Cytokines Levels in Children Affected by Atopic and Nonatopic Eczema
Ricci, G., Patrizi, A., Bellini, F., Calamelli, E., Dell'Omo, V., Bendandi, B., & Masi, M. (2008) · The Open Dermatology Journal · doi:10.2174/1874372200802010018 · Cited by 6
Role of Barrier Dysfunction and Immune Response in Atopic Dermatitis
Novak, N., & Leung, D. Y. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00050-1 · Cited by 5
Self-citationHost Defense Peptides: Immune Modulation and Antimicrobial Activity In Vivo
Afacan, N. J., Janot, L., & Hancock, R. E. W. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0541-4_13 · Cited by 4
Gavrilita, E., Silion, S., Bîtcă, M., & Tatu, A. L. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s459096 · Cited by 4
Wise, R. D. (2006) · Comprehensive Therapy · doi:10.1385/comp:32:2:111 · Cited by 4
Stefanaki, C., Stefanaki, I., Verra, P., Hadjivassiliou, M., Caroni, C., Bethimoutis, G., Papadogeorgaki, H., Stavropoulos, P., Kostaki, M., Antoniou, C., et al. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010225 · Cited by 4
Jalian, H. R., & Kim, J. J. (2008) · Springer eBooks · doi:10.1007/978-1-84800-165-7_9 · Cited by 4
Evaluation of Canine Antimicrobial Peptides in Infected and Noninfected Chronic Atopic Skin
Santoro, D., Bunick, D., Graves, T. K., & Segre, M. (2013) · doi:10.1002/9781118644317.ch6 · Cited by 4
You, Z., Zhang, X., Huang, S., Chen, D., Zhu, Y., Li, G. L., & Chen, X. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae244 · Cited by 3
Role of Barrier Dysfunction and Immune Response in Atopic Dermatitis
Novak, N., & Leung, D. Y. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00053-5 · Cited by 3
Self-citationOccupational MRSA Infection: Risk Factor, Disposition, Prevention, and Therapy
Brans, R., Kaup, O., & Schürer, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-40221-5_98-2 · Cited by 3
Role of Stratum Corneum in Permeability Barrier Function and Antimicrobial Defense
Elias, P. M. (2011) · Wiley eBooks · doi:10.1002/9781118025338.ch3 · Cited by 4
Boguniewicz, M., & Leung, D. Y. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00035-8 · Cited by 2
Self-citationIMMUNOLOGICAL FEATURES OF ALLERGIC AND NON-ALLERGIC FORMS OF ATOPIC DERMATITIS
Shestakova, N. A., Borisov, V. I., Pronkina, N. V., Trufakina, E. V., Shishkova, I. V., Демина, Д. В., Leonova, M. I., Nepomnyashikh, V. M., & Kozhevnikov, V. S. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2009-6-531-540 · Cited by 2
Update on Atopic Eczema with Special Focus on Dryness and the Impact of Moisturizers
Simpson, E. L. (2012) · Springer eBooks · doi:10.1007/978-3-642-27606-4_16 · Cited by 2
Novel Endogenous Antimicrobial Peptides
Nordahl, E. A. (2009) · Cited by 2
Chan, L. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-84744-5.00011-5 · Cited by 1
Regulación de la homeostasis de la barrera cutánea: implicaciones fisiopatológicas
Truchuelo, M. T., Reyes, E., Jaén, P., Delgado, A., & Vitale, M. (2015) · Piel · doi:10.1016/j.piel.2015.04.011 · Cited by 1
Evaluation of bacterial colonization in patients with the diagnosis of mycosis fungoides
Akay, B. N., Parlak, N., Sanlı, H. E., & Azap, A. (2014) · TURKDERM · doi:10.4274/turkderm.26928 · Cited by 1
Crespo, C. (2017) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2017.05.00143 · Cited by 1
Chan, L. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-84744-5.00003-6 · Cited by 1
Occupational MRSA Infection: Risk Factor, Disposition, Prevention, and Therapy
Brans, R., Kaup, O., & Schürer, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-68617-2_98 · Cited by 1
Antimikrobielle Peptide bei atopischer Dermatitis
Gläser, R., Meyer‐Hoffert, U., & Harder, J. (2009) · Der Hautarzt · doi:10.1007/s00105-009-1836-8 · Cited by 1
Boguniewicz, M., & Leung, D. Y. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05659-5.00062-0 · Cited by 1
Self-citationThe Immune-pathogenesis of Canine Atopic Dermatitis: Skin barrier, Microbiome and Inflammation
Chermprapai, S. (2019) · Utrecht University Repository (Utrecht University) · Cited by 1
Eziopatogenesi della dermatite atopica
Girolomoni, G., Gisondi, P., & Boner, A. L. (2008) · Springer eBooks · doi:10.1007/978-88-470-0775-8_13
Self-citationEffect of Defensins on Susceptibility to Infection at the Mucosal Surface
Guthmiller, J. M., & Joly, S. (2007) · Wiley eBooks · doi:10.1128/9781555815851.ch18
Sigurdardottir, S. L. (2014) · Skemman
Neonatal innate immunity - A translational perspective
Belderbos, M. E. (2012) · Utrecht University Repository (Utrecht University)
In vivo evaluation of therapeutic options in atopic dermatitis
Oldhoff, J. M. (2006) · Utrecht University Repository (Utrecht University)
ANTIMICROBIAL ACTIVITIES OF HISTIDINE-RICH GLYCOPROTEIN AND CATIONIC PEPTIDES
Rydengård, V. (2007) · Lund University Publications (Lund University)
Reefer, A. J., Satinover, S. M., Wilson, B. B., & Woodfolk, J. A. (2007)
Nepomnyashikh, V. M., & Kozhevnikov, V. S. (2009) · CyberLeninK (CyberLeninka)
Virus Infections in Atopic Dermatitis
Novak, N. (2009) · CRC Press eBooks · doi:10.3109/9781420077995-17
Self-citationNeue Erkenntnisse zur Hautbarrierefunktion
Bußmann, C., & Novak, N. (2009) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-540-77148-7_3
Self-citationInnate Immunity in Atopic Dermatitis
Hata, T. R., & Gallo, R. L. (2009) · CRC Press eBooks · doi:10.3109/9781420077995-7
Self-citationSantoro, D. (2013) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
SEVERE ATOPIC DERMATITIS AND T-CELL LYMPHOMA: SIMILARITIES AND DIFFERENCES
Niyasov, D. D., Fedenko, E. S., & Boldireva, M. N. (2012) · Russian Journal of Allergy · doi:10.36691/rja675
Tekucheva, L. V., & Znamenskaya, L. F. (2011) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1003
Schmid‐Grendelmeier, P., Zeller, S., & Crameri, R. (2009) · CRC Press eBooks · doi:10.3109/9781420077995-15
Topical Immune Response Modifiers: Antiinflammatories
Luger, T. A., McDonald, I., & Steinhoff, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_46
Spergel, J. M. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1087210.540206
Advances in Current Drugs and Formulations for the Management of Atopic Dermatitis
Atluri, K., Manne, S., Nalamothu, V., Mantel, A., Sharma, P. K., & Babu, R. J. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2023042979
Occupational MRSA Colonization and Infection: Risk Factors, Prevention, and Therapy
Brans, R., & Kaup, O. (2025) · Springer eBooks · doi:10.1007/978-3-319-40221-5_98-3
Dermatite atopica: eziopatogenesi
Girolomoni, G., Gisondi, P., & Pastore, S. (2007) · Springer eBooks · doi:10.1007/978-88-470-0593-8_5
Self-citationTopical Immune Response Modifiers: Antiinflammatories
Luger, T. A., & Steinhoff, M. S. (2008) · Springer eBooks · doi:10.1007/978-1-84800-165-7_30
Cutaneous expression of β-defensins in atopic dogs
van Damme, C. M. M. (2008) · Utrecht University Repository (Utrecht University)
Zhang, W., Ishida, Y., Kuninaka, Y., Ishigami, A., Nosaka, M., Kimura, A., Yamamoto, H., Osako, M., Matsuki, R., & Kondo, T. (2026) · International Journal of Legal Medicine · doi:10.1007/s00414-026-03841-x
Metadata
- Authors
- Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M.
- Affiliations
- National Jewish Health (US)
- University of Bonn (DE)
- Istituto Dermopatico dell'Immacolata (IT)
- University of California San Diego (US)
- Corresponding author
- Leung, Donald Y.M.
- ORCID
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 125
- Issue
- 4
- Pages
- 738-745
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2092527023
- Cited by
- 193
- References
- 34
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 3 · 2015: 9 · 2014: 10 · 2013: 13 · 2012: 9
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (454/1-1, 454/2-1)
- National Institutes of Health (T32 AI 07365)
- Ministero della Salute (AI052453, HL37260, HL36577, R21 AR051634-01, AR45676, AR41256)
- Cancer Center, University of Colorado
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- IL-10, atopic dermatitis, antimicrobial peptides, human beta-defensin 2, LL-37, skin infections, intrinsic atopic dermatitis, extrinsic atopic dermatitis, keratinocytes, IL-4, IL-13, TNF-α, interferon-gamma, psoriasis
- MeSH terms
- Adult, Cells, Cultured, Dermatitis, Atopic, Gene Expression Regulation, Humans, Immunohistochemistry, Middle Aged, Psoriasis, Down-Regulation, Interleukin-10, Interleukin-13, beta-Defensins, Antimicrobial Cationic Peptides, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review